Analysis of whole-blood cyclosporin g by liquid chromatography in renal transplant recipients
β Scribed by Dr. James H. McBride; Steaven S. Kim
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 459 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0887-8013
No coin nor oath required. For personal study only.
β¦ Synopsis
Cyclosporin G (CsG) is less nephrotoxic than CyclosporinA (CsA) and is undergoing clinical trials for use as an immunosuppressive agent after renal transplantation. In this study, CsG was measured by a rapid highperformance liquid chromatography (HPLC) technique in blood samples (n=107) received from renal transplant recipients. The HPLC assay proved to be analytically suitable in that it was sensitive, linear, and precise and had high recovery (1 02%). However, interference was observed from some potentially co-administered drugs such as calcitriol, ferrous sulfate, hydrazaline, and minoxidil.
The HPLC assay for CsG correlated well with a FPlA (Abbott TD,), FPlA = 0.964 (HPLC) + 33.59, r = 0.981 9, SYlx = 36.66 for patients receiving a low dose of CsG (5 mg/kg/day) and a high dose (10 mg/kg/ day). Furthermore, the HPLC technique was capable of measuring predictable CsG concentrations when the drug was tapered to lower doses at various stages of the 16 week clinical trial. The HPLC for CsG has the further advantage that the same system and mobile phase can be used to measure CsA while using CsC as the interval standard. o 1995Wiley-Liss, inc.
π SIMILAR VOLUMES
## Abstract Therapy with cyclosporin A (CsA) for immunosuppression after organ transplantation requires monitoring of its levels in blood owing to the narrow therapeutic index of the drug and to the high interβindividual variability of the drug absorption and metabolism. We describe the preparation
Human cytomegalovirus-infected cell polypeptides were immunoreacted by sera of renal transplant recipients and compared with those reactive with sera of healthy adult donors by means of the Western immunoblotting technique. At least 15 polypeptides with molecular weights of 155K, 123K, 102K, 89K, 79